Anavex Life Sciences Corp. (AVXL)
USD 8.54
(-2.06%)
USD 8.54
(-2.06%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -151.02 Million USD | -1.25% |
| 2022 | -149.15 Million USD | 1.94% |
| 2021 | -152.1 Million USD | -420.04% |
| 2020 | -29.24 Million USD | -31.84% |
| 2019 | -22.18 Million USD | 3.25% |
| 2018 | -22.93 Million USD | 16.43% |
| 2017 | -27.44 Million USD | -198.69% |
| 2016 | -9.18 Million USD | 39.58% |
| 2015 | -15.2 Million USD | -1026.04% |
| 2014 | -1.35 Million USD | -906.14% |
| 2013 | -134.21 Thousand USD | -146.66% |
| 2012 | 287.63 Thousand USD | -60.77% |
| 2011 | 733.21 Thousand USD | -67.09% |
| 2010 | 2.22 Million USD | 3.35% |
| 2009 | 2.15 Million USD | 39.64% |
| 2008 | 1.54 Million USD | 6174672.0% |
| 2007 | -25.00 USD | -100.32% |
| 2006 | 7725.00 USD | 890.69% |
| 2005 | -977.00 USD | 96.52% |
| 2004 | -28.11 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -138.75 Million USD | 0.45% |
| 2024 Q1 | -143.76 Million USD | 4.81% |
| 2024 Q2 | -139.38 Million USD | 3.05% |
| 2023 Q2 | -153.46 Million USD | -6.85% |
| 2023 Q3 | -154.81 Million USD | -0.88% |
| 2023 Q4 | -151.02 Million USD | 2.45% |
| 2023 FY | -151.02 Million USD | -1.25% |
| 2023 Q1 | -143.62 Million USD | 3.71% |
| 2022 Q1 | -151.14 Million USD | 0.63% |
| 2022 Q4 | -149.15 Million USD | 2.64% |
| 2022 FY | -149.15 Million USD | 1.94% |
| 2022 Q3 | -153.19 Million USD | 0.09% |
| 2022 Q2 | -153.34 Million USD | -1.45% |
| 2021 FY | -152.1 Million USD | -420.04% |
| 2021 Q1 | -47.35 Million USD | -61.91% |
| 2021 Q2 | -75.85 Million USD | -60.18% |
| 2021 Q3 | -157.56 Million USD | -107.7% |
| 2021 Q4 | -152.1 Million USD | 3.46% |
| 2020 FY | -29.24 Million USD | -31.84% |
| 2020 Q4 | -29.24 Million USD | -5.9% |
| 2020 Q2 | -26.56 Million USD | 3.26% |
| 2020 Q1 | -27.45 Million USD | -23.77% |
| 2020 Q3 | -27.61 Million USD | -3.98% |
| 2019 Q3 | -21.24 Million USD | -9.21% |
| 2019 FY | -22.18 Million USD | 3.25% |
| 2019 Q4 | -22.18 Million USD | -4.41% |
| 2019 Q2 | -19.45 Million USD | 6.07% |
| 2019 Q1 | -20.71 Million USD | 9.66% |
| 2018 Q4 | -22.93 Million USD | 11.22% |
| 2018 FY | -22.93 Million USD | 16.43% |
| 2018 Q1 | -28.04 Million USD | -2.22% |
| 2018 Q2 | -25.65 Million USD | 8.53% |
| 2018 Q3 | -25.82 Million USD | -0.67% |
| 2017 Q2 | -23.35 Million USD | -10.35% |
| 2017 Q4 | -27.44 Million USD | -10.68% |
| 2017 Q1 | -21.16 Million USD | -130.35% |
| 2017 FY | -27.44 Million USD | -198.69% |
| 2017 Q3 | -24.79 Million USD | -6.17% |
| 2016 Q2 | -11.86 Million USD | 13.86% |
| 2016 Q3 | -9.63 Million USD | 18.74% |
| 2016 Q4 | -9.18 Million USD | 4.69% |
| 2016 Q1 | -13.77 Million USD | 9.44% |
| 2016 FY | -9.18 Million USD | 39.58% |
| 2015 Q1 | -1.72 Million USD | -27.63% |
| 2015 Q4 | -15.2 Million USD | -92.04% |
| 2015 Q3 | -7.91 Million USD | -30.09% |
| 2015 FY | -15.2 Million USD | -1026.04% |
| 2015 Q2 | -6.08 Million USD | -253.17% |
| 2014 Q1 | 104.43 Thousand USD | 177.82% |
| 2014 Q2 | -8.99 Million USD | -8716.51% |
| 2014 Q3 | -7.97 Million USD | 11.35% |
| 2014 FY | -1.35 Million USD | -906.14% |
| 2014 Q4 | -1.35 Million USD | 83.07% |
| 2013 Q2 | 760.8 Thousand USD | 46.53% |
| 2013 FY | -134.21 Thousand USD | -146.66% |
| 2013 Q4 | -134.21 Thousand USD | -117.75% |
| 2013 Q3 | 755.95 Thousand USD | -0.64% |
| 2013 Q1 | 519.21 Thousand USD | 80.51% |
| 2012 FY | 287.63 Thousand USD | -60.77% |
| 2012 Q1 | 1.14 Million USD | 56.44% |
| 2012 Q4 | 287.63 Thousand USD | 833.74% |
| 2012 Q3 | 30.8 Thousand USD | -96.99% |
| 2012 Q2 | 1.02 Million USD | -10.89% |
| 2011 Q4 | 733.21 Thousand USD | 285.74% |
| 2011 FY | 733.21 Thousand USD | -67.09% |
| 2011 Q3 | -394.75 Thousand USD | -301.04% |
| 2011 Q2 | 196.35 Thousand USD | 187.75% |
| 2011 Q1 | -223.78 Thousand USD | -110.05% |
| 2010 FY | 2.22 Million USD | 3.35% |
| 2010 Q3 | 2.1 Million USD | -38.69% |
| 2010 Q4 | 2.22 Million USD | 5.75% |
| 2010 Q1 | 2.53 Million USD | 17.44% |
| 2010 Q2 | 3.43 Million USD | 35.73% |
| 2009 FY | 2.15 Million USD | 39.64% |
| 2009 Q3 | 1.78 Million USD | -7.55% |
| 2009 Q2 | 1.92 Million USD | 14.41% |
| 2009 Q1 | 1.68 Million USD | 9.09% |
| 2009 Q4 | 2.15 Million USD | 21.02% |
| 2008 Q3 | 1.29 Million USD | 93.79% |
| 2008 Q1 | 151.41 Thousand USD | 605772.0% |
| 2008 Q4 | 1.54 Million USD | 19.64% |
| 2008 FY | 1.54 Million USD | 6174672.0% |
| 2008 Q2 | 665.81 Thousand USD | 339.72% |
| 2007 Q2 | 69.97 Thousand USD | 351.94% |
| 2007 Q1 | 15.48 Thousand USD | 100.44% |
| 2007 Q3 | 272.88 Thousand USD | 289.95% |
| 2007 Q4 | -25.00 USD | -100.01% |
| 2007 FY | -25.00 USD | -100.32% |
| 2006 Q2 | -130.00 USD | 0.0% |
| 2006 Q1 | -130.00 USD | 86.69% |
| 2006 FY | 7725.00 USD | 890.69% |
| 2006 Q3 | 119.00 USD | 191.54% |
| 2006 Q4 | 7725.00 USD | 6391.6% |
| 2005 FY | -977.00 USD | 96.52% |
| 2005 Q4 | -977.00 USD | 0.0% |
| 2004 FY | -28.11 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Keros Therapeutics, Inc. | -316.7 Million USD | 52.314% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 108.076% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -799.541% |
| AlloVir, Inc. | -62.69 Million USD | -140.898% |
| Precigen, Inc. | -481 Thousand USD | -31297.921% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 13.814% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -6418.008% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -715.471% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2477.201% |
| Acelyrin, Inc. | -216.9 Million USD | 30.373% |
| AbCellera Biologics Inc. | -55.94 Million USD | -169.975% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 236.217% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1240.751% |
| Agenus Inc. | 274.13 Million USD | 155.091% |
| Dyadic International, Inc. | -6.37 Million USD | -2267.853% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -847.869% |
| Lantern Pharma Inc. | -21.7 Million USD | -595.858% |
| Immix Biopharma, Inc. | -17.5 Million USD | -762.512% |
| IO Biotech, Inc. | -140.69 Million USD | -7.338% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1341.64% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -94.993% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -16.969% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -170.342% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 346.542% |
| Alkermes plc | -166.73 Million USD | 9.425% |
| Aptorum Group Limited | 1.35 Million USD | 11228.878% |
| Ardelyx, Inc. | 34.51 Million USD | 537.599% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3628.598% |
| Bicycle Therapeutics plc | -481.46 Million USD | 68.633% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 517.62% |
| Chimerix, Inc. | -25.51 Million USD | -491.856% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2267.37% |
| CRISPR Therapeutics AG | -150.84 Million USD | -0.119% |
| Elevation Oncology, Inc. | -19.11 Million USD | -689.957% |
| ESSA Pharma Inc. | -33.62 Million USD | -349.188% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2070.307% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2070.307% |
| NextCure, Inc. | -6.47 Million USD | -2231.697% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -199.052% |
| Onconetix, Inc. | 5.33 Million USD | 2932.707% |
| Opthea Limited | 28.15 Million USD | 636.355% |
| PDS Biotechnology Corporation | -32.7 Million USD | -361.721% |
| GT Biopharma, Inc. | -1.02 Million USD | -14691.773% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -36.628% |
| ImmuCell Corporation | 10.99 Million USD | 1474.124% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 2.025% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1667.773% |
| Incyte Corporation | -3.17 Billion USD | 95.243% |
| Jaguar Health, Inc. | 29.39 Million USD | 613.844% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2929.755% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2976.472% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -989.954% |
| ContextLogic Inc. | -232 Million USD | 34.903% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 974.083% |
| MiMedx Group, Inc. | -33.9 Million USD | -345.485% |
| MEI Pharma, Inc. | -3.7 Million USD | -3976.221% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1581.354% |
| Seer, Inc. | -4.24 Million USD | -3461.887% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2591.922% |
| Novavax, Inc. | -298.29 Million USD | 49.371% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1172.537% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2267.518% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -395.811% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 10.229% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 193.373% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2290.469% |
| Vaxcyte, Inc. | -368.22 Million USD | 58.986% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -171.558% |
| Pharming Group N.V. | 109.8 Million USD | 237.54% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 37.687% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -768.154% |
| PureTech Health plc | -167.19 Million USD | 9.673% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 643.389% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -715.471% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2027.099% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -8660.093% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2119.962% |
| Senti Biosciences, Inc. | 1.74 Million USD | 8779.54% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 18.192% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2391.323% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 151473.673% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 24148.408% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -528.298% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -29.03% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1307.13% |
| ChromaDex Corporation | -24.04 Million USD | -528.011% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1888.204% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -537.851% |
| Precision BioSciences, Inc. | -85.41 Million USD | -76.822% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 344.906% |
| Innoviva, Inc. | 255.56 Million USD | 159.095% |
| Summit Therapeutics Inc. | 34.67 Million USD | 535.554% |
| GlycoMimetics, Inc. | -40.98 Million USD | -268.491% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -122.805% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -12.638% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -423.081% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -200372.562% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -389.353% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1742.912% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4726.562% |
| Soligenix, Inc. | -4.95 Million USD | -2950.006% |
| Century Therapeutics, Inc. | 847 Thousand USD | 17930.46% |
| Kura Oncology, Inc. | -20.11 Million USD | -650.691% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -269.017% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1698.333% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 8390.301% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4623.929% |
| Autolus Therapeutics plc | -186.59 Million USD | 19.065% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -206.312% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 45.24% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 540.714% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 191.882% |
| GRI Bio, Inc. | -1.79 Million USD | -8318.283% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1581.211% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -354.112% |
| IGM Biosciences, Inc. | -72.6 Million USD | -108.005% |
| INmune Bio, Inc. | -25.41 Million USD | -494.325% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 200.048% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -198.119% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -829.414% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5134.935% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 497.275% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -266.697% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 573.652% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 139.959% |
| Verastem, Inc. | -37.27 Million USD | -305.129% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1564.543% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -191.204% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -897.846% |
| Histogen Inc. | -7.48 Million USD | -1917.15% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -598.964% |
| Surrozen, Inc. | -32.66 Million USD | -362.356% |
| Organovo Holdings, Inc. | -1.5 Million USD | -9921.5% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3492.826% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 896.531% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5873.089% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3733.879% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1701.948% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -247.645% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -936.053% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 52.327% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -20815.713% |
| Apollomics, Inc. | -27.39 Million USD | -451.283% |
| Amarin Corporation plc | -191.04 Million USD | 20.946% |
| Mesoblast Limited | 55.96 Million USD | 369.864% |
| Turnstone Biologics Corp. | -14.58 Million USD | -935.546% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -497.122% |
| Synaptogenix, Inc. | -28.66 Million USD | -426.923% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -16035.043% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 409.907% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -17418.377% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1978.48% |
| Exelixis, Inc. | -73.05 Million USD | -106.741% |
| Better Therapeutics, Inc. | -860 Thousand USD | -17460.93% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -528.926% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 37.431% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 20617.725% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1930.401% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 12143.381% |
| Gritstone bio, Inc. | 39.49 Million USD | 482.436% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -79.575% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -5637.689% |
| Avid Bioservices, Inc. | 169.72 Million USD | 188.98% |
| Insmed Incorporated | 721.62 Million USD | 120.928% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1552.068% |
| MediWound Ltd. | -5.32 Million USD | -2737.73% |
| OmniAb, Inc. | 9.2 Million USD | 1741.03% |
| Alector, Inc. | -35.63 Million USD | -323.784% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 275.669% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2964.61% |
| Zai Lab Limited | -775 Million USD | 80.513% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 144.346% |
| Aura Biosciences, Inc. | -21.52 Million USD | -601.621% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -83.104% |
| Immunic, Inc. | -45.34 Million USD | -233.092% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 21.836% |
| Veracyte, Inc. | -203.82 Million USD | 25.905% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 123.661% |
| FibroGen, Inc. | 56.76 Million USD | 366.042% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1795.946% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5242.045% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -7194.619% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.29% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4420.323% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 9.002% |
| TG Therapeutics, Inc. | 17.86 Million USD | 945.504% |
| Galecto, Inc. | -21.21 Million USD | -611.84% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -534.955% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 109.623% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -517.13% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1212.453% |
| XBiotech Inc. | -200.02 Million USD | 24.497% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -79.575% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3435.336% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -328.279% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -95.581% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2753.734% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 11.379% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -63.492% |
| Vaxxinity, Inc. | 10.13 Million USD | 1590.565% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 120.512% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1302.584% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -128.977% |
| NexImmune, Inc. | -3.13 Million USD | -4719.439% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4274.118% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -899.401% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -457.284% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1582.521% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -121131.387% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -272.237% |
| Ainos, Inc. | 4.07 Million USD | 3803.449% |
| Pluri Inc. | 22.82 Million USD | 761.545% |
| Prothena Corporation plc | -608.34 Million USD | 75.175% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -27.172% |
| Celularity Inc. | 65.19 Million USD | 331.667% |
| Rallybio Corporation | -24.1 Million USD | -526.604% |
| Cue Biopharma, Inc. | -33.81 Million USD | -346.566% |
| MeiraGTx Holdings plc | -40.3 Million USD | -274.731% |
| Omeros Corporation | 331.17 Million USD | 145.602% |
| Humacyte, Inc. | -22.48 Million USD | -571.636% |
| Immunocore Holdings plc | -358.59 Million USD | 57.884% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -514.543% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -388.735% |
| Blueprint Medicines Corporation | 702.83 Million USD | 121.488% |
| CalciMedica, Inc. | -5.53 Million USD | -2630.995% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 19.762% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1378.598% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -277.211% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -354.167% |
| Pulmatrix, Inc. | -10.41 Million USD | -1349.784% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2426.753% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -295.952% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -35.567% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -151.942% |
| Cytokinetics, Incorporated | 642.37 Million USD | 123.51% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2493.577% |
| Nutriband Inc. | -251.65 Thousand USD | -59911.842% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -342.639% |
| Vor Biopharma Inc. | 4.3 Million USD | 3612.186% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.498% |
| Evogene Ltd. | -19.63 Million USD | -669.196% |
| ProKidney Corp. | -56.23 Million USD | -168.554% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -210.289% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1534.957% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 111.073% |
| CorMedix Inc. | -43.05 Million USD | -250.79% |
| BioLineRx Ltd. | 7.33 Million USD | 2158.67% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -449.878% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 427.267% |
| Atai Life Sciences N.V. | -28.55 Million USD | -428.833% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6870.771% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -561.921% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 951.559% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -101.167% |
| MediciNova, Inc. | -50.78 Million USD | -197.388% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -91.643% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -671266.97% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2240.518% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 24.42% |
| Biomea Fusion, Inc. | -166.57 Million USD | 9.333% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 15.617% |
| Mereo BioPharma Group plc | -51.46 Million USD | -193.427% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -59.234% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 48.589% |
| Absci Corporation | -72.59 Million USD | -108.028% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3407.578% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 35.58% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -60.304% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -57.816% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -286.518% |
| Allakos Inc. | -24.97 Million USD | -504.701% |
| Imunon, Inc. | -4.21 Million USD | -3483.989% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -924.447% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -11.539% |
| BioAtla, Inc. | -109.01 Million USD | -38.54% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 20617.725% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -15983.493% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1362.109% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -612.277% |
| XOMA Corporation | -29 Million USD | -420.772% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -811.981% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1575.067% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1927.44% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -21.172% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 27.45% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -84.673% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -62.806% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -17477.609% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3827.802% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 9405.868% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 110.937% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -12611.013% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3539.399% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 233.083% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 209966.318% |
| Orgenesis Inc. | 21.78 Million USD | 793.279% |
| Entera Bio Ltd. | -10.62 Million USD | -1320.867% |
| GH Research PLC | -78.07 Million USD | -93.43% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -577.602% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -466.503% |
| Xencor, Inc. | 29.64 Million USD | 609.459% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -7566.925% |
| Replimune Group, Inc. | 1.41 Million USD | 10795.751% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -61565.605% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -19.465% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -12611.013% |
| Portage Biotech Inc. | -4.98 Million USD | -2932.002% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -671266.97% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -128.402% |
| OncoCyte Corporation | -6.56 Million USD | -2201.143% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 16928.818% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3215.097% |
| Purple Biotech Ltd. | -14.13 Million USD | -968.213% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -535.73% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2207.471% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -804.76% |
| HilleVax, Inc. | -165.48 Million USD | 8.739% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5850.512% |
| Tharimmune, Inc. | -10.93 Million USD | -1281.062% |
| Genprex, Inc. | -6.73 Million USD | -2141.501% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 59.051% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -70.726% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -10679.729% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4453.104% |
| OKYO Pharma Limited | -826.84 Thousand USD | -18165.026% |
| Savara Inc. | 153 Thousand USD | 98808.497% |
| Curis, Inc. | -23.88 Million USD | -532.243% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2828.007% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -19361.555% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2332.732% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 12844.641% |
| BeiGene, Ltd. | -2.25 Billion USD | 93.297% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1324.006% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 75.169% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 18.623% |
| Erasca, Inc. | -37.21 Million USD | -305.804% |
| bluebird bio, Inc. | 108.57 Million USD | 239.102% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -11626.44% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 139.875% |
| DBV Technologies S.A. | -126.98 Million USD | -18.93% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -11626.44% |
| Moderna, Inc. | -2.9 Billion USD | 94.805% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1358.887% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1289.621% |
| Molecular Templates, Inc. | 707 Thousand USD | 21461.245% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -381.413% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 143.572% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -84.036% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -64.64% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -367.972% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -339.33% |
| MacroGenics, Inc. | -66.98 Million USD | -125.459% |
| RenovoRx, Inc. | -1.17 Million USD | -12775.021% |
| Adicet Bio, Inc. | -138.78 Million USD | -8.817% |
| Prime Medicine, Inc. | -27.94 Million USD | -440.51% |
| Aditxt, Inc. | 18.12 Million USD | 933.425% |
| Adagene Inc. | -87.62 Million USD | -72.348% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3525.654% |
| Quantum-Si incorporated | -118.55 Million USD | -27.385% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 519.453% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1920.607% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -211.332% |
| SciSparc Ltd. | -2.06 Million USD | -7213.511% |
| Vericel Corporation | 1.27 Million USD | 11926.468% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1159.404% |
| Minerva Neurosciences, Inc. | 41 Million USD | 468.313% |
| Generation Bio Co. | 31.44 Million USD | 580.234% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 13.88% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -388.387% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 229.531% |
| Invivyd, Inc. | -198.47 Million USD | 23.908% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -67.303% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -6198.734% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -113.341% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2112.806% |
| 2seventy bio, Inc. | 181.71 Million USD | 183.11% |
| ADMA Biologics, Inc. | 90.06 Million USD | 267.681% |
| Clene Inc. | 3.34 Million USD | 4621.677% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1562.765% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -602.078% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2240.518% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 56.113% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -480.869% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 185.004% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3591.104% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3119.272% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2799.29% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -15.901% |
| Evaxion Biotech A/S | 5.28 Million USD | 2956.6% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -34.162% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -15.046% |
| Trevena, Inc. | 2.25 Million USD | 6788.397% |
| Surrozen, Inc. | -32.66 Million USD | -362.356% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -193.194% |
| Cingulate Inc. | 3.08 Million USD | 4999.109% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5042.118% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2201.35% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1525.447% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -90.391% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -14.889% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -43.094% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3730.533% |
| Kronos Bio, Inc. | -36.05 Million USD | -318.883% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1705.101% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 10457.397% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -178.354% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1147.584% |
| ImmunityBio, Inc. | 618.22 Million USD | 124.429% |
| Korro Bio, Inc. | -132.94 Million USD | -13.601% |
| Kineta, Inc. | -4.54 Million USD | -3225.787% |
| BioVie Inc. | -17.73 Million USD | -751.686% |
| Codexis, Inc. | -43.27 Million USD | -249.019% |
| Celularity Inc. | 65.19 Million USD | 331.667% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4665.667% |
| Celcuity Inc. | 6.78 Million USD | 2326.34% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4388.158% |
| Cibus, Inc. | -8.07 Million USD | -1769.572% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3471.152% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3404.683% |
| IN8bio, Inc. | -16.38 Million USD | -821.496% |
| Kodiak Sciences Inc. | -103.87 Million USD | -45.39% |
| Annexon, Inc. | -193.75 Million USD | 22.054% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 419611.111% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -763.044% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4199.004% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 114.325% |
| Eyenovia, Inc. | 1.25 Million USD | 12098.392% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 661.323% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4556.923% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -354.249% |
| Arcellx, Inc. | -296.95 Million USD | 49.143% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -674.244% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -156.516% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -628.634% |
| Moolec Science SA | 117.61 Thousand USD | 128504.299% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -293.302% |
| Geron Corporation | 14.76 Million USD | 1123.129% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -298.291% |
| Royalty Pharma plc | 5.65 Billion USD | 102.669% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -6.79% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2060.75% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2716.11% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -7.314% |
| Humacyte, Inc. | -22.48 Million USD | -571.636% |
| Structure Therapeutics Inc. | -124.33 Million USD | -21.461% |
| 89bio, Inc. | -289.05 Million USD | 47.752% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -498.304% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -8370.219% |
| Genelux Corporation | -6.89 Million USD | -2089.071% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -386.249% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 280.653% |
| Notable Labs, Ltd. | -9.77 Million USD | -1444.845% |
| Liquidia Corporation | -80.17 Million USD | -88.366% |
| Mustang Bio, Inc. | -3.73 Million USD | -3942.398% |
| Immunovant, Inc. | -635.22 Million USD | 76.225% |
| Quantum-Si incorporated | -118.55 Million USD | -27.385% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -759.85% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3545.281% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1981.45% |
| Acasti Pharma Inc. | -23 Million USD | -556.483% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4385.112% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -829.414% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -9.644% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4746.164% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -579.309% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -713.313% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 10.783% |
| PepGen Inc. | -60.67 Million USD | -148.927% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -557.312% |
| United Therapeutics Corporation | -507.7 Million USD | 70.253% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -689.627% |
| Solid Biosciences Inc. | -47.75 Million USD | -216.281% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -17418.377% |
| Immuneering Corporation | -54.94 Million USD | -174.875% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3492.826% |
| Silo Pharma, Inc. | -3.52 Million USD | -4185.21% |
| Belite Bio, Inc | -87.27 Million USD | -73.052% |
| XOMA Corporation | -29 Million USD | -420.772% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -113.622% |
| Bionomics Limited | 227 Million USD | 166.527% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -29.877% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5862.258% |
| uniQure N.V. | -102.95 Million USD | -46.695% |
| Cassava Sciences, Inc. | -121.13 Million USD | -24.673% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3525.654% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 468.792% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1162.637% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4780.874% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 142575.472% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4556.923% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1795.946% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1936.462% |
| Altimmune, Inc. | -134.48 Million USD | -12.296% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 176.25% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5862.258% |
| Compugen Ltd. | -12.9 Million USD | -1070.366% |
| Peak Bio, Inc. | 10.34 Million USD | 1560.558% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -53265.371% |
| Benitec Biopharma Inc. | -50.58 Million USD | -198.573% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -44.745% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 868.766% |
| Zura Bio Limited | -99.8 Million USD | -51.318% |
| PolyPid Ltd. | 6.17 Million USD | 2547.715% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 303.756% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 868.766% |
| Instil Bio, Inc. | 75.35 Million USD | 300.409% |
| argenx SE | -2.02 Billion USD | 92.556% |
| Immunome, Inc. | -97.02 Million USD | -55.648% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -571.367% |
| Verona Pharma plc | -220.44 Million USD | 31.491% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -110.507% |
| Shattuck Labs, Inc. | -121.42 Million USD | -24.377% |
| CervoMed Inc. | -7.79 Million USD | -1837.983% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 18.585% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3353.556% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -14.638% |
| Moolec Science SA | 117.61 Thousand USD | 128504.299% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -6500.766% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1049.933% |
| AnaptysBio, Inc. | -18.15 Million USD | -732.042% |
| Design Therapeutics, Inc. | -18.15 Million USD | -732.088% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -114.581% |
| NeurAxis, Inc. | 145.7 Thousand USD | 103754.084% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1444.587% |
| Lumos Pharma, Inc. | -28.49 Million USD | -430.039% |
| Achilles Therapeutics plc | -126.92 Million USD | -18.988% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -110.507% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -22931.431% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -626.992% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 10457.397% |
| Nutriband Inc. | -251.65 Thousand USD | -59911.842% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1046.64% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1929.892% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 144.393% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 736.292% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 66.249% |
| Palisade Bio, Inc. | -12.06 Million USD | -1151.961% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -7.635% |
| Beam Therapeutics Inc. | -262.72 Million USD | 42.516% |
| Neurogene Inc. | -131.95 Million USD | -14.451% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 792.263% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2994.754% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 59.961% |
| Sesen Bio, Inc. | -112.55 Million USD | -34.18% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -51.236% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -6332.594% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -286.983% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -81.341% |
| Athira Pharma, Inc. | -88.99 Million USD | -69.692% |
| Vaccinex, Inc. | -1.28 Million USD | -11625.466% |
| HCW Biologics Inc. | 2.85 Million USD | 5386.704% |
| XOMA Corporation | -29 Million USD | -420.772% |
| Nektar Therapeutics | 210.24 Million USD | 171.834% |
| Arvinas, Inc. | -313.8 Million USD | 51.873% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 9405.868% |
| Merus N.V. | -192.88 Million USD | 21.702% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 351.77% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2076.766% |
| Rezolute, Inc. | -68.16 Million USD | -121.547% |
| Clene Inc. | 3.34 Million USD | 4621.677% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1045.249% |
| BeyondSpring Inc. | -13.75 Million USD | -997.957% |
| Synlogic, Inc. | -6.68 Million USD | -2159.147% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 13417.813% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1686.209% |
| Peak Bio, Inc. | 10.34 Million USD | 1560.558% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -83.237% |
| Krystal Biotech, Inc. | -350.23 Million USD | 56.879% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 221.671% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 10.635% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4683.564% |
| MannKind Corporation | 143.89 Million USD | 204.951% |
| Ikena Oncology, Inc. | -109.15 Million USD | -38.356% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1894.77% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -356.266% |
| Gossamer Bio, Inc. | 180.35 Million USD | 183.737% |
| CohBar, Inc. | -5.93 Million USD | -2446.465% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -407.678% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3407.578% |
| Legend Biotech Corporation | -949.39 Million USD | 84.093% |
| Mural Oncology plc | -255.84 Million USD | 40.97% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 568.8% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3106.017% |
| Disc Medicine, Inc. | -358.28 Million USD | 57.848% |
| Champions Oncology, Inc. | 4.81 Million USD | 3238.487% |
| REGENXBIO Inc. | 54.76 Million USD | 375.752% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -56062.168% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1575.809% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -87.182% |
| Vaxart, Inc. | -8.24 Million USD | -1732.593% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -200.965% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -18.762% |
| Cellectis S.A. | -43.85 Million USD | -244.371% |
| Longeveron Inc. | -2.9 Million USD | -5093.398% |
| Repare Therapeutics Inc. | -107.85 Million USD | -40.021% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 115.596% |
| Inozyme Pharma, Inc. | 12 Million USD | 1358.114% |
| Revolution Medicines, Inc. | -608.2 Million USD | 75.169% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -12178.374% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 43.035% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -0.634% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -865.195% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -20308.649% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.421% |
| Denali Therapeutics Inc. | -74.86 Million USD | -101.728% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1159.404% |
| Veru Inc. | 4.77 Million USD | 3259.518% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1242.913% |
| Cingulate Inc. | 3.08 Million USD | 4999.109% |
| Passage Bio, Inc. | 4.58 Million USD | 3393.871% |
| Context Therapeutics Inc. | -14.44 Million USD | -945.161% |
| Exicure, Inc. | 5.84 Million USD | 2682.048% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 34.445% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -281.663% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1062.488% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -156.752% |
| Nuvalent, Inc. | -335.38 Million USD | 54.97% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 8807.861% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -102.766% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1598.808% |
| OmniAb, Inc. | 9.2 Million USD | 1741.03% |
| Anew Medical, Inc. | 1.43 Million USD | 10642.945% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1021.904% |
| Lipocine Inc. | -4.75 Million USD | -3076.382% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -37.51% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1091.557% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -198.119% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 706.717% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2147.047% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -129.426% |
| Ocugen, Inc. | -32.52 Million USD | -364.389% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -76.481% |
| Q32 Bio Inc. | -37.94 Million USD | -297.976% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -23948.408% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1016.298% |
| Equillium, Inc. | -22.39 Million USD | -574.455% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -490.676% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -362.884% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -60817.653% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 212.669% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4822.452% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 46082.079% |
| Dominari Holdings Inc. | 195 Thousand USD | 77548.205% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2767.412% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1593.664% |
| Bio-Techne Corporation | 267.74 Million USD | 156.405% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -831.729% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -27.885% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1697.263% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1093.771% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 38.387% |
| Nkarta, Inc. | 57.29 Million USD | 363.572% |
| BioCardia, Inc. | 212 Thousand USD | 71337.736% |
| Iterum Therapeutics plc | 13.43 Million USD | 1223.858% |